BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15572205)

  • 1. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum.
    Hsieh YS; Yang SF; Kuo DY
    Regul Pept; 2005 Apr; 127(1-3):169-76. PubMed ID: 15680483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional interruption of cAMP response element binding protein modulates superoxide dismutase and neuropeptide Y-mediated feeding behavior in freely moving rats.
    Hsieh YS; Yang SF; Chu SC; Ho YJ; Kuo CS; Kuo DY
    J Neurochem; 2008 May; 105(4):1438-49. PubMed ID: 18221372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Kuo DY; Yang SF; Chu SC; Chen CH; Chen PN; Hsieh YS
    J Neurochem; 2010 Aug; 114(4):1217-30. PubMed ID: 20533995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.
    Kuo DY
    Regul Pept; 2005 Apr; 127(1-3):19-26. PubMed ID: 15680466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting oxidative stress in the hypothalamus: the effect of transcription factor STAT3 knockdown on endogenous antioxidants-mediated appetite control.
    Kuo DY; Chen PN; Hsieh YS
    Arch Toxicol; 2015 Jan; 89(1):87-100. PubMed ID: 24792324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
    Hsieh YS; Kuo MH; Chen PN; Kuo DY
    Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation of oxidative stress in hypothalamic ghrelin-associated appetite control in rats treated with phenylpropanolamine.
    Yu CH; Chu SC; Chen PN; Hsieh YS; Kuo DY
    Genes Brain Behav; 2017 Apr; 16(4):439-448. PubMed ID: 27862969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Horm Behav; 2013 Jun; 64(1):95-102. PubMed ID: 23707533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
    Hsieh YS; Yang SF; Kuo DY
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toluene alters appetite, NPY, and galanin immunostaining in the rat hypothalamus.
    Morón L; Pascual J; Portillo MP; Casis L; Macarulla MT; Abecia LC; Echevarría E
    Neurotoxicol Teratol; 2004; 26(2):195-200. PubMed ID: 15019953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
    Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
    Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats.
    Kuo DY; Chen PN; Chu SC; Hsieh YS
    Arch Toxicol; 2012 Mar; 86(3):453-63. PubMed ID: 21989786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.